findmyKOL
Clinical trialNCT01716026CompletedPhase 3Interventional

Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia

SponsorInstituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBAEnrollment66Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Chus - Fundacion Idichus

    Santiago de Compostela, La Coruña, Spain

  • Clinica Universitaria de Navarra

    Pamplona, Navarre, Spain

  • Complejo Hospitalario de Albacete

    Albacete, Spain

  • Hospital Clinico Universitario San Carlos

    Madrid, Spain

  • Hospital Universitario Ramón Y Cajal

    Madrid, Spain

  • Hospital Reina Sofia

    Murcia, Spain

  • Hospital Virgen de Valme

    Seville, Spain

  • Hospital Virgen de la Macarena

    Seville, Spain

  • Hospital General Universitario de Valencia

    Valencia, Spain

  • Hospital Universitario Rio Hortega

    Valladolid, Spain

  • Ioba - Instituto Universitario de Oftalmobiologia Aplicada

    Valladolid, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2012
Primary completion
30 Apr 2018
Completion
30 Apr 2018
Last update posted
13 Mar 2023
Registered enrollment
66
Registry id
NCT01716026
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.